ZyVersa Therapeutics, Inc. - Common Stock (NQ:ZVSA)

0.3113 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ZyVersa Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 12, 2023

Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.

Via InvestorPlace

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase

April 11, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Announces Article Published in Brain Pathology Addressing Inflammasome Signaling Proteins in Alzheimer’s Disease

April 10, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today? ↗

March 23, 2023

ZyVersa Therapeutics (ZVSA) stock is taking off on Thursday morning without any recent news from the biopharmaceutical company.

Via InvestorPlace

ZyVersa Therapeutics Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results

April 03, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 23, 2023

Via Benzinga

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today? ↗

March 23, 2023

Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 23, 2023

Via Benzinga

Why Is Coinbase (COIN) Stock Down 15% Today? ↗

March 23, 2023

Coinbase Global (COIN) stock is falling on Thursday after the SEC threatened to investigate the crypto exchange's business.

Via InvestorPlace

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 23, 2023

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.

Via Benzinga

Why Is Advent Technologies (ADN) Stock Up 32% Today? ↗

March 23, 2023

Advent Technologies (ADN) stock is climbing higher on Thursday following news of a fuel cell agreement with Hyundai (HYMTF).

Via InvestorPlace

Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

March 23, 2023

Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 23, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

ZyVersa Therapeutics Reports New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 13, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Adds Dr. Richard J. Glassock to Its Renal Scientific Advisory Board to Support Clinical Advancement of Renal Cholesterol Efflux Mediator™ VAR 200

March 07, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics to Participate in a Fireside Chat at Oppenheimer Healthcare Conference

March 01, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics to Participate in a Fireside Chat at Roth Annual Conference

February 27, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Announces New Publication in Translational Research Showing IC 100 Reduces Inflammasome Activation in Mouse Model for Alzheimer’s Disease Following Traumatic Brain Injury

February 23, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 17, 2023

We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!

Via InvestorPlace

Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

February 16, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 16, 2023

It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!

Via InvestorPlace

Genius Group (GNS) Stock Skyrockets 39% on NFT Plans ↗

February 02, 2023

Genius Group (GNS) stock is taking off on Thursday after the company revealed plans to offer NFTs coupons with its shares.

Via InvestorPlace

Why Is OncoSec Medical (ONCS) Stock Down 25% Today? ↗

February 02, 2023

OncoSec Medical (ONCS) stock is falling on Thursday after the company revealed some details of a planned stock offering.

Via InvestorPlace

Why Is TeraWulf (WULF) Stock Down 34% Today? ↗

February 02, 2023

TeraWulf (WULF) stock is taking a beating on Thursday after the crypto mining company revealed plans for a public stock offering.

Via InvestorPlace

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today? ↗

February 02, 2023

ZyVersa Therapeutics (ZVSA) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 02, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

Why Meta Platforms Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket ↗

February 02, 2023

Gainers Tenax Therapeutics, Inc (NASDAQ: TENX) shares rose 172.8% to $4.61 in pre-market trading. Tenax was granted a Notice of Allowance for U.S. Patent application for use of IV levosimendan in...

Via Benzinga

ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)

January 27, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 26, 2023

We're starting off the day with an overview of the biggest pre-market stock movers that traders need to watch on Thursday!

Via InvestorPlace

ZyVersa Therapeutics to Present at BIO CEO & Investor Conference

January 25, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.